Home > Boards > US OTC > Food - Beverages > MusclePharm Corporation (MSLP)

MusclePharm Announces Third Quarter 2020 Financial Results December 01,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
turokman Member Profile
 
Followed By 18
Posts 3,742
Boards Moderated 1
Alias Born 10/12/11
160x600 placeholder
MusclePharm names former Yum! Brands C-suite executive as CFO and President Seeking Alpha - 4/8/2021 12:48:32 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/7/2021 5:16:20 PM
MusclePharm reports Q4 results Seeking Alpha - 3/30/2021 10:56:59 AM
Annual Report (10-k) Edgar (US Regulatory) - 3/29/2021 5:19:53 PM
Sec Staff Action/letter (sec Staff) Edgar (US Regulatory) - 3/26/2021 5:17:27 PM
Sec Staff Action/letter (sec Staff) Edgar (US Regulatory) - 3/26/2021 5:16:21 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 1/29/2021 12:04:31 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/25/2021 6:02:03 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/8/2021 6:04:19 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/22/2020 5:00:56 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/3/2020 12:53:08 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 12/2/2020 4:58:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/1/2020 5:01:11 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/1/2020 12:51:19 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/24/2020 6:05:03 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/24/2020 6:03:49 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/24/2020 6:03:43 AM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 10/28/2020 3:58:08 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/1/2020 4:16:42 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/27/2020 4:36:31 PM
Annual Report (10-k) Edgar (US Regulatory) - 8/25/2020 9:31:11 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/25/2020 9:30:40 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/25/2020 9:29:33 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/25/2020 9:28:29 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/28/2020 4:35:36 PM
turokman   Thursday, 12/31/20 06:30:01 AM
Re: None
Post # of 80574 
MusclePharm Announces Third Quarter 2020 Financial Results
December 01, 2020

CALABASAS, Calif., Dec. 01, 2020 (GLOBE NEWSWIRE) -- MusclePharm Corp Inc. (OTCQB: MSLP), a global provider of leading sports nutrition & lifestyle branded nutritional supplements, today reported financial results for the quarter and nine months ended September 30, 2020.

The following are key financial highlights for the period. Reconciliations of certain GAAP to non-GAAP measures are provided later in this press release.

Third Quarter 2020 Compared to Third Quarter 2019

Revenue, net was $16.1 million compared to $21.2 million.
Gross margin improved to 31.2% compared to 7.2%.
Net income was $678,000 compared to a net loss of $(5.1) million.
Diluted income per share was $0.01 compared to diluted loss per share of $(0.27).
Adjusted EBITDA was $1.0 million compared to negative Adjusted EBITDA of $(4.1) million.

http://ir.musclepharmcorp.com/prviewer/release_only/id/4548989

$MSLP

$MSLP - Every Dog Has Its Day .
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences